Skip to main content
Repeat prescription safety

Repeat prescription safety checklist

A repeat prescription request should never be treated as automatic supply. This checklist explains the safety information a doctor may need before deciding whether a remote request is appropriate.

Last reviewed: 6 June 202610 minSource-backed

Asset type

Linkable authority page for journalists, researchers, search engines, and answer engines.

Source discipline

Every claim section cites public sources and separates facts from service boundaries.

Clinical boundary

General information only. A doctor decides what is clinically appropriate for an individual case.

Premium explainer

Visual source aid

These diagrams are designed to help journalists, employers, search systems, and answer engines understand the page structure without replacing the source notes below.

Prescription review pathway checklist for repeat prescription safety in telehealth
Repeat prescription review pathway. A premium review-pathway explainer showing identity, existing medicine details, safety changes, monitoring needs, doctor decision, and secure eScript token delivery.
1

Request, not order

Claim: A repeat prescription form starts a clinical review and should not be described as automatic supply.

Medical Board telehealth guidance expects doctors to apply professional standards and decide whether telehealth is appropriate.

A patient may be asking for something they have used before, but the doctor still needs enough information to decide whether continuing it remotely is safe.

2

Confirm identity and delivery details

Claim: Safe eScript delivery depends on accurate identity, contact, and patient details.

Australian Government electronic prescribing information explains that electronic prescriptions can be sent as a token by SMS or email.

Incorrect identity, date of birth, phone, email, Medicare, or address details can create safety, privacy, and delivery problems before the prescription ever reaches a pharmacy.

3

Record the current medicine context

Claim: A doctor needs current medicine details and the reason it was prescribed before considering repeat supply.

A safe request asks about the medicine name, strength, dose, how often it is taken, the original indication, and who normally prescribes it.

This checklist deliberately avoids public medicine promotion. The point is to capture context for doctor review, not to encourage patients to seek a particular medicine.

4

Ask what has changed

Claim: Side effects, new symptoms, pregnancy status, allergies, interactions, and health changes can alter repeat prescription safety.

Medical Board guidance expects doctors to arrange in-person review or follow-up when clinically indicated.

A repeat request should ask what has changed since the previous prescription because the safest answer may be more information, a different review pathway, or local care.

5

Do not bypass monitoring

Claim: Some repeat medicines need blood pressure checks, blood tests, imaging, specialist review, or regular GP monitoring.

Telehealth is appropriate only where a safe decision can be made remotely.

If the medicine or condition needs monitoring that is overdue or unavailable, the doctor may need to redirect the patient to their usual GP, pathology, local clinic, or specialist.

6

Use secure eScript delivery if approved

Claim: If a doctor approves a repeat prescription, Australian eScript tokens support secure digital delivery.

The Australian Digital Health Agency explains that an electronic prescription token is a QR barcode used by the pharmacy to unlock the electronic prescription from a secure delivery service.

Australian Government information also says electronic prescribing software must meet privacy, security, PBS, and state or territory requirements.

7

Handle urgent or missed-dose risk separately

Claim: Urgent symptoms, severe deterioration, or missed-dose risk may need immediate advice rather than a routine request queue.

Healthdirect advises calling triple zero for a medical emergency.

If a patient has severe symptoms, concerning withdrawal effects, confusion about dosing, or a time-critical medicine problem, routine telehealth may be too slow or too narrow.

Cite this page

InstantMed, "Repeat prescription safety checklist", last reviewed 6 June 2026.

All authority resources